SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-037365
Filing Date
2023-02-14
Accepted
2023-02-14 08:17:11
Documents
47
Period of Report
2023-02-14

Document Format Files

Seq Description Document Type Size
1 6-K d252981d6k.htm 6-K 9914
2 EX-99.1 d252981dex991.htm EX-99.1 68684
3 GRAPHIC g252981ex99_1p10g1.jpg GRAPHIC 314007
4 GRAPHIC g252981ex99_1p11g1.jpg GRAPHIC 359419
5 GRAPHIC g252981ex99_1p12g1.jpg GRAPHIC 323493
6 GRAPHIC g252981ex99_1p13g1.jpg GRAPHIC 234130
7 GRAPHIC g252981ex99_1p14g1.jpg GRAPHIC 263821
8 GRAPHIC g252981ex99_1p15g1.jpg GRAPHIC 277635
9 GRAPHIC g252981ex99_1p16g1.jpg GRAPHIC 211226
10 GRAPHIC g252981ex99_1p17g1.jpg GRAPHIC 297419
11 GRAPHIC g252981ex99_1p18g1.jpg GRAPHIC 236867
12 GRAPHIC g252981ex99_1p19g1.jpg GRAPHIC 317806
13 GRAPHIC g252981ex99_1p1g1.jpg GRAPHIC 323777
14 GRAPHIC g252981ex99_1p20g1.jpg GRAPHIC 289132
15 GRAPHIC g252981ex99_1p21g1.jpg GRAPHIC 365307
16 GRAPHIC g252981ex99_1p22g1.jpg GRAPHIC 302330
17 GRAPHIC g252981ex99_1p23g1.jpg GRAPHIC 307747
18 GRAPHIC g252981ex99_1p24g1.jpg GRAPHIC 285195
19 GRAPHIC g252981ex99_1p25g1.jpg GRAPHIC 313736
20 GRAPHIC g252981ex99_1p26g1.jpg GRAPHIC 245476
21 GRAPHIC g252981ex99_1p27g1.jpg GRAPHIC 391137
22 GRAPHIC g252981ex99_1p28g1.jpg GRAPHIC 248586
23 GRAPHIC g252981ex99_1p29g1.jpg GRAPHIC 254055
24 GRAPHIC g252981ex99_1p2g1.jpg GRAPHIC 579167
25 GRAPHIC g252981ex99_1p30g1.jpg GRAPHIC 295776
26 GRAPHIC g252981ex99_1p31g1.jpg GRAPHIC 376097
27 GRAPHIC g252981ex99_1p32g1.jpg GRAPHIC 229885
28 GRAPHIC g252981ex99_1p33g1.jpg GRAPHIC 344681
29 GRAPHIC g252981ex99_1p34g1.jpg GRAPHIC 372538
30 GRAPHIC g252981ex99_1p35g1.jpg GRAPHIC 346270
31 GRAPHIC g252981ex99_1p36g1.jpg GRAPHIC 252699
32 GRAPHIC g252981ex99_1p37g1.jpg GRAPHIC 249837
33 GRAPHIC g252981ex99_1p38g1.jpg GRAPHIC 277760
34 GRAPHIC g252981ex99_1p39g1.jpg GRAPHIC 226476
35 GRAPHIC g252981ex99_1p3g1.jpg GRAPHIC 446621
36 GRAPHIC g252981ex99_1p40g1.jpg GRAPHIC 241666
37 GRAPHIC g252981ex99_1p41g1.jpg GRAPHIC 253581
38 GRAPHIC g252981ex99_1p42g1.jpg GRAPHIC 204317
39 GRAPHIC g252981ex99_1p43g1.jpg GRAPHIC 239175
40 GRAPHIC g252981ex99_1p44g1.jpg GRAPHIC 212784
41 GRAPHIC g252981ex99_1p45g1.jpg GRAPHIC 195388
42 GRAPHIC g252981ex99_1p4g1.jpg GRAPHIC 349873
43 GRAPHIC g252981ex99_1p5g1.jpg GRAPHIC 253941
44 GRAPHIC g252981ex99_1p6g1.jpg GRAPHIC 231978
45 GRAPHIC g252981ex99_1p7g1.jpg GRAPHIC 307402
46 GRAPHIC g252981ex99_1p8g1.jpg GRAPHIC 259413
47 GRAPHIC g252981ex99_1p9g1.jpg GRAPHIC 312011
  Complete submission text file 0001193125-23-037365.txt   18295926
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41562 | Film No.: 23622751
SIC: 2834 Pharmaceutical Preparations